Abstract: Method and materials for determining levels of .beta.-adrenergic blocking drugs in body fluid, the method including the step of measuring inhibition of the binding of .beta.-adrenergic receptor binder to .beta.-adrenergic receptor material caused by .beta.-adrenergic blocking drug present in the body fluid.